1Ackerman M J, Priori SG, Willems S, et al. HRS/EHRA expert consensus state- ment on the state of genetic testing for the channelopathies and cardiomyopa- thies:this document was developed as a partnership between the Heart Rhythm Society(HRS) and the European Heart Rhythm Association (EHRA) [ J ]. Eu- ropace, 2011,13 ( 8 ) : 1077-1109.
2Wichter T, Paul M, Wollmann C, et al. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy:single-center experi- ence of long-term follow-up and complications in 60 patients[ J]. Circulation, 2004,109(12) :1503-1508.
3Corrado D, Basso C, Thiene G. Arrhythmogenic fight ventricular cardiomyopathy: diagnosis, prognosis, and treatment [ J ]. Heart,2000,83:588 -595.
4Wozniak O, Wlodarska EK. Prevention ot sudden cardiac deaths m arrhythmo- genie fight ventricular eardiomyopathy : how to evaluate risk and when to im- plant a cardioverter-defibrillator[ J]? Cardiol J,2009,16(6) :588-591.
